Dataset from An Adaptive Seamless Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Investigate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00012937
下载链接
链接失效反馈官方服务：
资源简介：
Efficacy and safety of LNP023 in IgAN patients
创建时间：
2026-03-27
